James T. Parsons Dia Medica Therapeutics Inc. (DMAC) insider trading activity

James T. Parsons is of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 97,949 shares of DMAC, which is worth approximately $583,776. The most recent transaction as insider was on Jan 02, 2026, when has been sold 10,095 shares (Common Stock) at a price of $8.42 per share, resulting in proceeds of $84,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97.9K

29.13% 3M change

29.13% 12M change

Total Value Held $583,776

James T. Parsons Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	BUY Grant, award, or other acquisition	$84,999 $8.42 p/Share	10,095 Added 9.34%	97,949 Common Stock
Nov 21 2025	BUY Exercise of conversion of derivative security	$26,400 $2.2 p/Share	12,000 Added 12.02%	87,854 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	$84,996 $5.34 p/Share	15,917 Added 17.34%	75,854 Voting Common Shares, ...
Jan 02 2024	BUY Grant, award, or other acquisition	$59,998 $2.8 p/Share	21,428 Added 26.34%	59,937 Voting Common Shares, ...
Jan 03 2022	BUY Grant, award, or other acquisition	$60,047 $3.58 p/Share	16,773 Added 30.34%	38,509 Voting Common Shares, ...
Jan 01 2021	BUY Grant, award, or other acquisition	$63,741 $8.23 p/Share	7,745 Added 26.08%	21,947 Voting Common Shares, ...

JTP

James T. Parsons

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Value

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

Operation

Value

Type

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC

Account